SeekingAlpha · Mar 4, 2026
NASDAQ · MASS
908 Devices Inc.
Healthcare · Medical - Devices
$10.98
Down-$0.37 (-3.37%)
Updated Sep 18, 2026, 7:42 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 231.99M
- P/E ratio
- -56.02
- Dividend yield
- 0.00%
- 52-week range
- $5.03 – $11.25
- Volume
- 689.79K
- Avg. volume
- 390.2K
Price performance
MASS price history
1M range · 20 trading sessions · Daily adjusted prices
MASS closed at $10.98 after 20 trading sessions, up 6.09% for the selected period.
- Last close
- $10.98
- Period change
- +6.09%
- Period low
- $9.35
- Period high
- $11.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $10.15 | $11.22 | $10.15 | $10.98 | 689.79K |
| Sep 16, 2026 | $10.12 | $10.35 | $9.77 | $9.92 | 285.72K |
| Sep 15, 2026 | $9.67 | $10.00 | $9.66 | $9.97 | 249.38K |
| Sep 14, 2026 | $9.38 | $9.89 | $9.33 | $9.73 | 252.7K |
| Sep 11, 2026 | $9.49 | $9.73 | $9.44 | $9.52 | 279.73K |
| Sep 10, 2026 | $9.77 | $9.87 | $9.32 | $9.35 | 309.33K |
| Sep 9, 2026 | $9.68 | $9.70 | $9.55 | $9.69 | 235.37K |
| Sep 8, 2026 | $9.91 | $10.00 | $9.70 | $9.81 | 241.82K |
| Sep 4, 2026 | $10.02 | $10.12 | $9.87 | $10.05 | 201.07K |
| Sep 3, 2026 | $10.39 | $10.53 | $9.79 | $10.04 | 307.31K |
| Sep 2, 2026 | $10.70 | $11.00 | $10.30 | $10.33 | 535.61K |
| Sep 1, 2026 | $10.56 | $10.875 | $10.50 | $10.65 | 380.58K |
| Aug 31, 2026 | $10.73 | $10.80 | $10.49 | $10.67 | 246.22K |
| Aug 28, 2026 | $11.01 | $11.05 | $10.50 | $10.73 | 557.1K |
| Aug 27, 2026 | $10.40 | $11.10 | $10.40 | $11.10 | 503.2K |
| Aug 26, 2026 | $10.96 | $11.02 | $10.315 | $10.37 | 461.18K |
| Aug 25, 2026 | $11.03 | $11.05 | $10.56 | $11.00 | 444.14K |
| Aug 24, 2026 | $11.00 | $11.2487 | $10.80 | $10.92 | 724.07K |
| Aug 21, 2026 | $10.41 | $10.69 | $10.15 | $10.68 | 528.31K |
| Aug 20, 2026 | $10.05 | $10.7027 | $9.91 | $10.35 | 700.46K |
Latest MASS news
The latest Smart Investors Daily articles mentioning MASS.
Stock researchCompany · Overview
MASS research
Overview
Company profile and research snapshot.
Company profile
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | Canaccord Genuity | Buy | — |
| Aug 12, 2026 | Roth Capital | Buy | — |
| Aug 12, 2026 | Stifel | Buy | — |
| Jul 29, 2026 | Roth Capital | Buy | — |
| Aug 5, 2025 | Leerink Partners | Outperform | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Mar 3, 2026
908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript
ChartMill · Mar 3, 2026
908 Devices Inc. (NASDAQ:MASS) Surpasses Q4 Revenue Estimates and Achieves Profitability Milestone
908 Devices beats Q4 revenue estimates, achieves positive adjusted EBITDA, and provides strong 2026 outlook, driving a positive market reaction.
Benzinga · Mar 3, 2026
908 Devices Sees FY2026 Sales $64.500M-$67.500M vs $65.331M Est
908 Devices (NASDAQ:MASS) sees FY2026 sales of $64.500 million-$67.500 million vs $65.331 million analyst estimate.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
